PATENT CLAIM ANALYSIS

Application Number: 16039365
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-09
Patent Classification: ["514", "411000"]

Abstract:
The disclosure relates to PRMT5 inhibitors, including optionally substituted N-alkyl-9H-carbazole analogs, derivatives thereof, and related compounds; synthesis methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating disorders of uncontrolled cellular proliferation and benign hematologic diseases using the compounds and compositions.

Claim (Index 23):
The method according to  claim 22 , wherein the cancer comprises prostate cancer, lung cancer, colon cancer, pancreatic cancer, head & neck cancer, skin cancer, brain cancer, breast cancer, testicular cancer, ovarian cancer, melanoma, glioma, lymphoma, or leukemia.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 95.0
- Lexical Diversity: 1.40541
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14776685', '15575253', '14421776', '14650826', '14678905']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7787122880950339
- 35 USC 102 Novelty (BERT): 0.5545249165701034
- Combined Prediction Score: 0.7562935509425409
- Mean Citation Score: 266.979244
- Max Citation Score: 503.619
- Similarity Product: 257.96595813632007

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test